Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Sep 29, 2017
Clinical News
China approves HCV drugs from Gilead and AbbVie
Read More
BioCentury
|
Sep 25, 2017
Company News
Gilead's Sovaldi gets Chinese approval
Read More
BioCentury
|
Oct 3, 2016
Clinical News
Exviera dasabuvir: Phase IIIb data
Read More
BioCentury
|
Dec 3, 2015
Company News
FDA reviewing once-daily Viekira Pak
Read More
BioCentury
|
Oct 21, 2015
Clinical News
Shorter ABT-493/ABT-530 regimen yields 100% SVR4
Read More
BioCentury
|
Aug 17, 2015
Clinical News
Exviera dasabuvir: Phase IIIb data
Read More
BioCentury
|
May 11, 2015
Clinical News
Exviera dasabuvir: Preliminary Phase IIIb data
Read More
BioCentury
|
Apr 13, 2015
Clinical News
Exviera dasabuvir: Phase IIIb data
Read More
BioCentury
|
Apr 13, 2015
Clinical News
Exviera dasabuvir: Phase IIIb data
Read More
BioCentury
|
Apr 8, 2015
Top Story
Enanta gains on Phase II HCV data
Read More
Items per page:
10
1 - 10 of 104
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help